Insiders I-Mab BOERSE MUENCHEN

Equities

Market Closed - BOERSE MUENCHEN Other stock markets 15:43:52 2024-06-28 EDT			5-day change	1st Jan Change
1.57 ^EUR	-0.63%		-1.26%	-5.99%

06-06	I-Mab Appoints Phillip Dennis as Chief Medical Officer	CI
06-05	I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	MT

I-Mab Appoints Phillip Dennis as Chief Medical Officer	06-06	CI
Verastem Names John Hayslip as Chief Medical Officer	04-18	MT
I-Mab Announces Chief Medical Officer Changes	04-15	CI
I-Mab Announces Executive Resignation	04-01	CI
I-Mab Announces Board Changes , Effective February 10, 2024	02-07	CI
I-Mab Names Raj Kannan CEO	23-06-22	MT
I-Mab Announces CEO Changes	23-06-22	CI
I-Mab Announces the Appointment of Raj Kannan as Member of the Board of Directors	23-06-22	CI
I-Mab Announces Board and Management Changes	23-04-03	CI
I-Mab Announces Management Changes	22-09-30	CI
I-Mab Announces Management Changes	22-08-30	CI
I-Mab Announces Executive Appointments	22-04-28	CI
I-Mab Announces Andrew Zhu Joins as President and Board Director	21-12-20	CI
I-Mab Announces Executive Changes	21-12-20	CI
I-Mab Announces Board Changes, Effective December 10, 2021	21-12-10	CI
I-Mab Names John Long CFO	21-11-01	MT
I-Mab Appoints Jielun Zhu as Chief Strategy Officer	21-11-01	CI
I-Mab Announces Committee Appointments	21-08-20	CI
I-Mab Appoints Andrew Zhu to Its Scientific Advisory Board	21-06-21	CI
I-Mab Announces Executive Appointments	21-06-01	CI

No results for this search